Free shipping on all orders over $ 500

WKYMVM TFA

Cat. No. M10147

All AbMole products are for research use only, cannot be used for human consumption.

WKYMVM TFA Structure
Synonym:

CAS# 187986-17-0

Size Price Availability Quantity
5mg USD 440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

WKYMVM TFA is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist. WKYMVM TFA activates several leukocyte effector functions such as chemotaxis, mobilization of complement receptor-3, and activation of the NADPH oxidase.

Chemical Information
Molecular Weight 970.13
Formula C43H62F3N9O9S2
CAS Number 1313730-09-4
Solubility (25°C) Water
Storage -20°C, protect from light, sealed
References

[1] T Christophe, et al. Scand J Immunol. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4

[2] T Christophe, et al. J Biol Chem. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2

Related FPR Products
TC-FPR 43

TC-FPR 43 is a potent FPR2 agonist.

PBP10 TFA salt

PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects.

ACT-389949

ACT-389949 is a first-in-class, potent, selective formyl peptide receptor 2/lipoprotein A4 receptor (FPR2)/(ALX) agonist with an EC50 value of 3 nM for FPR2/ALX entry into monocytes.Additionally, ACT-389949 is an excellent tool compound for in vitro and in vivo to further analyze FPR2-regulated activity, which could be used in the development of next-generation FPR signaling-regulated anti-inflammatory therapies.

N-Formyl-Met-Leu-Phe

N-Formyl-Met-Leu-Phe (fMLP) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR), which can inhibit TNF-alpha secretion.

WRW4

WRW4 is a selective antagonist of formyl peptide receptor 1 (FPR1) signaling, it inhibits WKYMVm binding to FPR1 (IC50 = 0.23 μM).

  Catalog
Abmole Inhibitor Catalog




Keywords: WKYMVM TFA, CAS# 187986-17-0 supplier, FPR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.